FAERS pharmacovigilance data for semaglutide — July 2024

roxy_nash said:

The useful move here is to separate what is established from what is widely repeated.

Agreed, though "tolerable" needs defining. A dose you tolerate by eating almost nothing is not tolerated, it is being paid for somewhere else — usually in lean mass, sometimes in adherence three months later.

Happy to go further on any of that.

Dr.PainCLE said:

The mechanism that matters here is not stomach emptying, it is central.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Taking it to my next appointment.

roxy_nash said:

The useful move here is to separate what is established from what is widely repeated.

I will push back on the "any working dose is fine" framing. The maintenance evidence sits overwhelmingly at the top studied dose, and the extension data shows regain tracking dose reduction rather than tracking stopping. Holding low is reasonable; pretending it is evidentially equivalent is not.

That is the short version; the long version is somebody else's post.

The figures, for anyone assembling their own picture. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

Moderator note: the sourcing question belongs in the vendor section and has been split out.